Ak-N鈥檓

General Information


DRACP ID  DRACP04371

Peptide Name   Ak-N鈥檓

Sequence  NKGLAKLLKIGLKALESVIQ

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C98H178N26O26

Absent amino acids  CDFHMPRTWY

Common amino acids  L

Mass  247576

Pl  10.8

Basic residues  4

Acidic residues  1

Hydrophobic residues  10

Net charge  3

Boman Index  -61

Hydrophobicity  40.5

Aliphatic Index  161

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35432369

Title  Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19160

DRACP is developed by Dr.Zheng's team.